Viewing nowRiseton Tablet 150 mg (Risedronate Sodium 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

MFDS item code 201003150 · Notified 2010.04.29 · Insurance code 642705420
Treatment and prevention of osteoporosis in postmenopausal women
This medication is used to treat and prevent osteoporosis in postmenopausal women. Osteoporosis is a condition where bones become weak and are more likely to fracture, commonly occurring in women after menopause. This drug helps to increase bone strength and reduce the risk of fractures. Therefore, it is important to take it regularly for osteoporosis management. It is effective for the treatment and prevention of osteoporosis.
As Risedronate Sodium, administer 150 mg orally once monthly. Food interferes with the absorption of this medication, so take it at least 30 minutes before consuming any food or beverages other than plain water at the beginning of the day. This medication should be taken with an adequate amount of plain water (170-230 mL) in an upright position. Do not chew or suck on it, and patients should not lie down for at least 30 minutes afterward.
Safety and efficacy in children under 18 years have not been established.
This medication can irritate the gastrointestinal mucosa, so patients with esophageal disorders, gastritis, duodenitis, or ulcers should use it with caution. After taking it, serious esophageal adverse reactions such as esophagitis, esophageal ulcers, and esophageal erosion can occur, so if symptoms like difficulty swallowing, chest pain, or heartburn appear, immediately stop taking the medication and consult a physician. When taking this medication, it should be taken with a sufficient amount of water, and patients should not lie down for at least 30 minutes afterward. Following the correct method of intake is crucial to prevent serious side effects. Patients with esophageal stricture or achalasia that delay esophageal transit, patients with hypocalcemia, pregnant or breastfeeding women, and patients with severe renal impairment should not use this medication. Patients who are allergic to lactose contained in this medication should also avoid it. Patients with upper gastrointestinal diseases or allergies to the dye contained in the medication should take it with caution. This medication can have various side effects, with symptoms such as dyspepsia, abdominal pain, diarrhea, headache, joint pain, muscle pain, dizziness, rash, etc., reported. Long-term use can rarely lead to osteonecrosis of the jaw, atypical femoral fractures, and severe bone, joint, and muscle pain, so any unusual symptoms should be reported to a physician immediately. Adequate intake of calcium and vitamin D is essential to prevent metabolic abnormalities like hypocalcemia, and these conditions should be well managed before taking the medication. This medication may have absorption interference when taken with other drugs or foods containing calcium, magnesium, or iron, so a time gap should be maintained during intake. Pregnant or breastfeeding women should avoid taking this medication or decide after consulting a physician, and safety for children under 18 years has not been established. In case of overdose, symptoms of hypocalcemia may occur, so immediately inform medical personnel and receive appropriate treatment. This medication should be stored out of reach of children, and care should be taken not to transfer it to another container.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, skin peeling, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough + fever, jaundice (yellowing of skin or eyes), severe systemic fatigue, sudden and very severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination changes
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering, at a temperature between 1 to 30 degrees Celsius at room temperature. Storing it this way helps maintain the drug's effectiveness for a long time.
Bright blue oval film-coated tablet
1 tablet/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.